Polygenic susceptibility to breast cancer and implications for prevention

被引:595
作者
Pharoah, PDP [1 ]
Antoniou, A
Bobrow, M
Zimmern, RL
Easton, DF
Ponder, BAJ
机构
[1] Strangeways Res Labs, Dept Oncol, Canc Res UK Human Canc Genet Grp, Cambridge CB1 8RN, England
[2] Strangeways Res Labs, Publ Hlth Genet Unit, Cambridge CB1 8RN, England
[3] Strangeways Res Labs, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England
[4] Addenbrookes Hosp, Dept Clin Genet, Cambridge CB1 2QQ, England
基金
英国医学研究理事会;
关键词
D O I
10.1038/ng853
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The knowledge of human genetic variation that will come from the human genome sequence makes feasible a polygenic approach to disease prevention, in which it will be possible to identify individuals as susceptible by their genotype profile and to prevent disease by targeting interventions to those at risk. There is doubt, however, regarding the magnitude of these genetic effects and thus the potential to apply them to either individuals or populations. We have therefore examined the potential for prediction of risk based on common genetic variation using data from a population-based series of individuals with breast cancer. The data are compatible with a log-normal distribution of genetic risk in the population that is sufficiently wide to provide useful discrimination of high- and low-risk groups. Assuming all of the susceptibility genes could be identified, the half of the population at highest risk would account for 88% of all affected individuals. By contrast, if currently identified risk factors for breast cancer were used to stratify the population, the half of the population at highest risk would account for only 62% of all cases. These results suggest that the construction and use of genetic-risk profiles may provide significant improvements in the efficacy of population-based programs of intervention for cancers and other diseases.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 22 条
[1]   Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Ponder, BAJ ;
Easton, D .
GENETIC EPIDEMIOLOGY, 2001, 21 (01) :1-18
[2]  
ANTONIOU AC, 2001, IN PRESS BR J CANC
[3]   1998 ASHG Presidential Address - Making genomic medicine a reality [J].
Beaudet, AL .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (01) :1-13
[4]   The new genetics - The new genetics in clinical practice [J].
Bell, J .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7131) :618-620
[5]   After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer [J].
Cui, JS ;
Antoniou, AC ;
Dite, GS ;
Southey, MC ;
Venter, DJ ;
Easton, DF ;
Giles, GG ;
McCredie, MRE ;
Hopper, JL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (02) :420-431
[6]  
Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843
[7]   How many more breast cancer predisposition genes are there? [J].
Douglas F Easton .
Breast Cancer Research, 1 (1)
[8]   How DNA microarrays and expression profiling will affect clinical practice [J].
Friend, SH .
BRITISH MEDICAL JOURNAL, 1999, 319 (7220) :1306-U77
[9]   Will genetics revolutionize medicine? [J].
Holtzman, NA ;
Marteau, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (02) :141-144
[10]   REPRODUCTIVE FACTORS AND BREAST-CANCER [J].
KELSEY, JL ;
GAMMON, MD ;
JOHN, EM .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) :36-47